Skip to main content
. 2021 Jan 7;13(1):73. doi: 10.3390/pharmaceutics13010073

Figure 4.

Figure 4

Effect of MLo1302 treatment on DNA methyltransferases (DNMTs) expression and on DNA methylation profile. (A) Western blot for DNMTs in cell lines treated with MLo1302. Beta-actin is used as normalizer. Band densitometry graphs are provided (treated versus control); (B) Dotblot for 5 mC in cell lines treated with MLo1302, and respective quantification. Results are normalized to Sybergreen; (C) Immunofluorescence for 5 mC in cell lines treated with MLo1302, and respective quantification; (D) Immunofluorescence for 5 hmC in NCCIT cell line treated with MLo1302; (E) RASSF1A promoter DNA methylation in cell lines treated with MLo1302. Results are normalized to beta-actin. * p < 0.05; ** p < 0.01; *** p < 0.001.